Anemia in Seniors: Causes, Iron vs B12 Deficiency & Treatment Guide

The WHO defines anemia as hemoglobin < 13 g/dL in men and < 12 g/dL in women. However, these thresholds may underestimate the problem in older adults — studies show that seniors with hemoglobin in the 12–13 g/dL range often have measurable impairment in exercise tolerance, cognition, and quality of life. The WHO definition was established in working-age adults; geriatric specialists increasingly use 13 g/dL as the lower limit for both sexes in seniors. More importantly, a decline from an individual's baseline — even within 'normal' range — can be clinically significant. Any new drop in hemoglobin of > 1 g/dL warrants investigation in an older adult.

Anemia of chronic disease/inflammation (ACD) is the most common single type in older adults, accounting for 30–45% of cases, because chronic conditions like CKD, heart failure, cancer, rheumatoid arthritis, and chronic infections are so prevalent in seniors. However, approximately one-third of older adults have multi-factorial anemia — two or more contributing causes simultaneously (e.g., iron deficiency from GI blood loss plus ACD from CKD plus B12 deficiency from atrophic gastritis). This is why a complete anemia workup — CBC with differential, reticulocyte count, iron studies, B12, folate, and renal function — is important before assuming a cause and starting treatment.

Iron supplements are effective for iron deficiency anemia, but three important senior-specific caveats: (1) Find the cause first — iron deficiency in seniors almost always means occult GI bleeding until proven otherwise. Starting iron supplements without investigating the bleeding source may mask a colon cancer or ulcer that continues to bleed. Always get an upper endoscopy and colonoscopy before attributing IDA to diet alone in seniors; (2) Every-other-day dosing — multiple randomized trials now show that ferrous sulfate 325mg taken every other day is as effective as daily dosing and causes significantly fewer GI side effects (constipation, nausea, abdominal pain) — a major advantage for seniors already prone to constipation; (3) IV iron for intolerance — if GI side effects prevent adequate oral dosing, IV iron (ferric carboxymaltose, iron sucrose) is safe and highly effective for seniors.

Yes — vitamin B12 deficiency can cause cognitive impairment that closely mimics dementia, including memory loss, confusion, personality changes, and impaired executive function. The neurological damage from B12 deficiency (subacute combined degeneration of the spinal cord) also causes peripheral neuropathy (numbness, tingling, balance problems) and gait instability — symptoms commonly attributed to neuropathy from diabetes or 'normal aging.' Critically, if B12 deficiency is caught early, correction of B12 levels can reverse cognitive and neurological symptoms. If allowed to progress for months to years, the damage becomes permanent. Every senior workup for cognitive impairment or unexplained neuropathy should include serum B12 — and if borderline (200–350 pg/mL), also methylmalonic acid (which is elevated in true deficiency even with 'low-normal' B12 levels).

The transfusion threshold has changed significantly — most evidence now supports a restrictive transfusion strategy (transfuse when hemoglobin < 7–8 g/dL) over a liberal strategy (transfuse at < 10 g/dL) for most patients. For seniors, guidelines generally recommend: transfuse if hemoglobin < 7 g/dL in otherwise stable patients; transfuse if hemoglobin < 8 g/dL in patients with cardiac disease (particularly acute coronary syndrome, heart failure, or symptomatic coronary artery disease); consider transfusion at higher thresholds if the patient has severe symptoms attributable to anemia (chest pain, syncope, hemodynamic compromise) regardless of the absolute number. Each unit of packed red blood cells typically raises hemoglobin by approximately 1 g/dL. Transfusion is not without risk — iron overload, transfusion reactions, TACO (transfusion-associated circulatory overload, common in seniors with heart failure or CKD), and infection transmission.

Anemia and heart failure form a dangerous cycle in seniors. Anemia reduces the oxygen-carrying capacity of blood, forcing the heart to pump more blood per minute to maintain tissue oxygen delivery — increasing cardiac workload, heart rate, and myocardial oxygen demand. This worsens heart failure symptoms (dyspnea, fatigue, edema) and can trigger acute decompensation. Conversely, heart failure causes kidney underperfusion → reduced erythropoietin production and impaired iron metabolism → anemia (the 'cardio-renal-anemia syndrome'). Studies show that anemia is present in 30–50% of heart failure patients and is independently associated with worse outcomes, more hospitalizations, and higher mortality. Treatment of anemia in heart failure improves exercise tolerance and quality of life. Intravenous iron (even without anemia, if ferritin < 100 or transferrin saturation < 20%) has shown survival benefit in HFrEF — IV iron is now a Class IIa recommendation in HF guidelines.

Several common senior medications can cause or worsen anemia: (1) Metformin — impairs B12 absorption from the gut; 10–30% of long-term users develop B12 deficiency; screen annually; (2) Proton pump inhibitors (omeprazole, pantoprazole) — reduce gastric acid needed for B12 release from food; also reduce iron absorption; risk with long-term use; (3) Methotrexate — folate antagonist; always co-prescribe folic acid 1 mg/day; (4) NSAIDs — cause GI bleeding (iron loss) and gastric ulcers; (5) Anticoagulants — can worsen bleeding from any source; (6) Chemotherapy agents — bone marrow suppression; (7) ACE inhibitors — reduce erythropoietin production (a modest effect, relevant in CKD). Polypharmacy review is essential in any senior with unexplained anemia.

The decision depends on the type, severity, cause, and symptoms. Anemia that should always be treated: iron deficiency (source of blood loss must be found and stopped, then iron replaced); B12 or folate deficiency (to prevent irreversible neurological damage); symptomatic anemia causing chest pain, dyspnea, syncope, or significantly impaired function. Anemia that may be observed with watchful waiting: very mild anemia of chronic disease in a stable patient with the underlying condition already optimized; anemia in someone with advanced illness where investigation and treatment burden outweighs benefit. The key principle in geriatrics is that 'mild' anemia is not benign in seniors — even hemoglobin 10–12 g/dL is associated with increased falls, cognitive decline, reduced physical performance, and hospitalizations. A watchful waiting decision should be conscious and revisited regularly, not a default to inaction.